Medical oxygen system is critical equipment used in hospitals, clinics, and other healthcare facilities to deliver oxygen to patients in need. These system can provide a reliable and continuous supply of oxygen to patients who are experiencing respiratory distress, as well as those who require oxygen therapy for chronic conditions.
Medical oxygen system typically consist of three main components: an oxygen source, a delivery system, and monitoring equipment. The oxygen source can be either a liquid oxygen tank or a concentrator that uses ambient air to extract oxygen. The delivery system includes piping, valves, and regulators that transport the oxygen from the source to the patient's point of use, such as an oxygen mask or nasal cannula. The monitoring equipment is used to ensure that the oxygen concentration is accurate and to alert healthcare providers to any potential problems.
Medical oxygen systems are used to treat a wide range of respiratory conditions, including chronic obstructive pulmonary disease (COPD), pneumonia, asthma, and respiratory distress syndrome. They can also be used during surgery or other medical procedures to maintain proper oxygen levels in the patient's blood. There are several different types of medical oxygen systems available, including portable systems for use outside of healthcare facilities and stationary systems for use within hospitals and clinics. Portable oxygen systems are designed to be lightweight and compact, allowing patients to move around freely while receiving oxygen therapy. Stationary systems, on the other hand, are typically larger and can provide a higher flow rate of oxygen to patients who require it. These systems have become even more critical during the COVID-19 pandemic, as patients with severe cases of the virus often require supplemental oxygen to help them breathe. The pandemic has also led to an increased demand for medical oxygen systems in low-and middle-income countries, where access to reliable oxygen systems has been limited.
Respiratory diseases like COPD and asthma have become increasingly common globally, contributing significantly to the growth of the medical oxygen systems market. According to the World Health Organization, more than 235 million people globally suffer from asthma, and COPD is the third leading cause of death globally, with more than 3 million deaths in 2019.
These respiratory diseases are chronic, often progressive, and require long-term treatment, with oxygen therapy being a critical part of the treatment plan. The increasing prevalence of these respiratory diseases, especially in the elderly population, has led to a growing demand for medical oxygen systems. With the advancements in medical technology and the development of portable oxygen concentrators, it has become easier for patients to receive oxygen therapy at home or while on-the-go, contributing to the growth of this market. As the incidence of respiratory diseases continues to rise, the demand for medical oxygen systems is expected to grow further in the coming years.
Technological advancements are playing a significant role in driving the growth of the medical oxygen systems market. With the development of new technologies, such as portable oxygen concentrators and oxygen conserving devices, patients are now able to receive oxygen therapy at home or while on-the-go. These advancements are expanding the market and making it easier for patients to manage their respiratory conditions. Portable oxygen concentrators are lightweight, compact devices that extract oxygen from the air and deliver it to patients who need it. They are much more convenient than traditional oxygen tanks and allow patients to continue their daily activities without being tethered to a stationary oxygen source. The development of portable oxygen concentrators has revolutionized the treatment of respiratory diseases and has significantly increased patient compliance.
Oxygen conserving devices, on the other hand, are designed to conserve oxygen and reduce wastage. These devices deliver oxygen only when the patient inhales, reducing the amount of oxygen used and prolonging the life of the oxygen source. The development of these devices has made oxygen therapy more cost-effective and has reduced the burden on healthcare systems. In addition to portable oxygen concentrators and oxygen conserving devices, other technological advancements, such as digital oxygen flow meters and smart oxygen delivery systems, are also driving the growth of the medical oxygen systems market. Digital oxygen flow meters provide more accurate and reliable readings, while smart oxygen delivery systems monitor the patient's oxygen usage and adjust the oxygen flow rate accordingly, ensuring that the patient receives the optimal amount of oxygen.
The growing adoption of telemedicine and remote patient monitoring is also contributing to the growth of the medical oxygen systems market. Patients can now receive medical care and oxygen therapy remotely, without having to visit a healthcare facility, increasing their convenience and reducing the risk of exposure to infections. As technology continues to advance, the medical oxygen systems market is expected to grow further, as new products and devices are developed to make oxygen therapy more accessible and efficient for patients.
New product launches to flourish in the marketIn January 2021, Inogen, a company that specializes in portable oxygen concentrators, launched its new Inogen One G5 portable oxygen concentrator. The device is designed to be lightweight, compact, and easy to use, allowing patients with respiratory conditions to stay active and maintain their independence. Moreover, in March 2021, Philips, a global leader in medical technology, announced the launch of its new Trilogy Evo Universal portable ventilator. The device is designed to provide respiratory support for a broad range of patients, from neonatal to adult, and can be used in a variety of care settings, including hospitals, long-term care facilities, and home care. Also, in May 2021, Chart Industries, a leading provider of cryogenic equipment for the medical and industrial gas markets, announced the launch of its new CAIREview telehealth platform. The platform allows healthcare providers to remotely monitor patients who are using oxygen therapy, providing real-time data and alerts to help optimize patient care. Furthermore, in June 2021, Nidek Medical, a manufacturer of respiratory care equipment, announced the launch of its new Prodigy 2 stationary oxygen concentrator. The device is designed to be compact and energy-efficient, making it a cost-effective solution for patients who require long-term oxygen therapy.
By product type: The medical oxygen systems market is divided into compressed oxygen cylinders, oxygen concentrators, and liquid oxygen systems. These systems are used to provide supplemental oxygen to patients with respiratory conditions, and each type has its own advantages and disadvantages. Compressed oxygen cylinders are typically used for short-term oxygen therapy, such as during hospitalization or transportation. Oxygen concentrators are more commonly used for long-term oxygen therapy and are able to provide a continuous supply of oxygen without the need for refilling or replacing cylinders. Liquid oxygen systems are another option for long-term oxygen therapy and are able to provide a high volume of oxygen in a compact, portable system. The choice of system depends on the patient's specific needs and the recommendations of their healthcare provider.
By modality: The medical oxygen systems market is divided into portable oxygen systems and stationary/standalone oxygen systems. Portable oxygen systems are designed for patients who require oxygen therapy on-the-go. They are lightweight and compact, and can be carried or wheeled around, allowing patients to maintain an active lifestyle. Portable oxygen systems include both compressed oxygen cylinders and portable oxygen concentrators. Stationary/standalone oxygen systems, on the other hand, are designed for patients who require oxygen therapy at home or in a healthcare facility. They are larger and less mobile than portable systems and are intended to provide a continuous supply of oxygen without the need for frequent refilling or replacement of the oxygen source. Stationary/standalone oxygen systems include both oxygen concentrators and liquid oxygen systems. The choice between portable and stationary/standalone oxygen systems depends on the patient's level of mobility and the frequency and duration of their oxygen therapy. Some patients may use a combination of both systems to meet their oxygen needs in different settings.
By end-user: The medical oxygen systems market is divided into hospitals, ambulatory surgical centers, and home care settings. Hospitals typically use stationary/standalone oxygen systems to provide oxygen therapy to patients who require acute or long-term care. Ambulatory surgical centers may use either stationary or portable oxygen systems to provide oxygen therapy during surgical procedures or for patients who require short-term oxygen therapy. Home care settings are becoming an increasingly important market for medical oxygen systems, as more patients are choosing to receive care in their homes rather than in healthcare facilities. Home care settings use both stationary and portable oxygen systems to provide oxygen therapy to patients with chronic respiratory diseases.
By region: The Asia-Pacific medical oxygen systems market is one of the fastest-growing markets globally. The increasing prevalence of respiratory diseases, growing geriatric population, and rising healthcare expenditure are some of the factors contributing to the growth of the market. The Asia-Pacific region has a large population, with increasing levels of air pollution and high rates of smoking, leading to a high incidence of respiratory diseases such as COPD and asthma. This has resulted in an increase in the demand for medical oxygen systems, particularly portable oxygen concentrators, in the region. In addition, the region has a large elderly population, which is also driving the demand for medical oxygen systems, as older adults are at higher risk of developing respiratory diseases.
Furthermore, the Asia-Pacific region is home to several emerging economies, such as China and India, which are experiencing significant economic growth and increasing healthcare spending. This has resulted in an expansion of healthcare infrastructure and an increase in the number of hospitals and other healthcare facilities, which is driving the demand for medical oxygen systems. Another factor contributing to the growth of the Asia-Pacific medical oxygen systems market is the increasing adoption of home healthcare services. Many patients in the region prefer to receive healthcare services in the comfort of their homes, which has led to an increase in demand for portable oxygen systems.
Competitive analysis and profiles of the major players in the medical oxygen systems market, such as Atlas Copco AB, Cryofab Inc, GF Health Products, Inc., Inogen Inc, Invacare Corporation, Keen Compressed Gas Company, Medtronic plc, Respironics, Inc., and Terumo Medical Co. are included in the report. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the medical oxygen systems market.
Key Market Segments
- By Product Type
- Compressed Oxygen Cylinders
- Oxygen Concentrators
- Liquid Oxygen Systems
- By Modality
- Portable Oxygen Systems
- Stationary/Standalone Oxygen Systems
- By End User
- Hospitals
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Malaysia
- Indonesia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Argentina
- Rest of LAMEA
Key Market Players
- Atlas Copco AB
- TERUMO MEDICAL CORPORATION
- Respironics, Inc.
- Cryofab Inc
- Medtronic plc
- Inogen Inc
- Invacare Corporation
- GF Health Products, Inc.
- keen compressed gas company